<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Talk:Anticonvulsant,Dieldrin,Endosulfan,Endrin,Pharmacology,Picrotoxin,Tetramethylenedisulfotetramine,WP:NPOV,Alphaquad,Colin,Spiperon" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Talk:Anticonvulsant - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-1">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Talk:Anticonvulsant</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <table class="messagebox standard-talk">
<tr>
<td><a href="../../../o/b/l/Image%7EOblongPills.JPG_a177.html" class="image" title=""><img src="../../../upload/thumb/e/ea/OblongPills.JPG/60px-OblongPills.JPG" alt="" width="60" height="45" longdesc="../../../o/b/l/Image%7EOblongPills.JPG_a177.html" /></a></td>
<td><b>Anticonvulsant</b> is part of <b><a href="../../../w/i/k/Wikipedia%7EWikiProject_Pharmacology_9728.html" title="Wikipedia:WikiProject Pharmacology">WikiProject Pharmacology</a></b>, a project to improve all <a href="../../../p/h/a/Pharmacology.html" title="Pharmacology">Pharmacology</a>-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.</td>
</tr>
<tr>
<td colspan="2">
<hr /></td>
</tr>
</table>
<p><a name="Convulsant" id="Convulsant"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Talk%7EAnticonvulsant_3512.html" title="Edit section: Convulsant">edit</a>]</span> <span class="mw-headline">Convulsant</span></h2>
<p>Is there an opposite to anti-convulsants ie a medicine that blocks or destroys GABA or by any other way?</p>
<dl>
<dd>1) Not all anticonvulsants are GABA-active. Some of them, yes.
<dl>
<dd>I know that's why I put "or by any other way"</dd>
</dl>
</dd>
<dd>2) Yes, there are compounds, that exhibit GABA-receptor-blockage. Commonly, these substances are (if they penetrate the brain-blood barier) convulsants, or convulsive poisons. Examples are some diene polychlorinated insecticides (<a href="../../../d/i/e/Dieldrin.html" title="Dieldrin">dieldrin</a>, <a href="../../../e/n/d/Endrin.html" title="Endrin">endrin</a>, <a href="../../../e/n/d/Endosulfan.html" title="Endosulfan">endosulfan</a> and the like) and <a href="../../../p/i/c/Picrotoxin.html" title="Picrotoxin">picrotoxin</a>, as well as other "cage convulsants", like <a href="../../../t/e/t/Tetramethylenedisulfotetramine.html" title="Tetramethylenedisulfotetramine">tetramine</a>, for example.--<a href="../../../s/p/i/User%7ESpiperon_5ebb.html" title="User:Spiperon">Spiperon</a> 22:01, 23 October 2006 (UTC)
<dl>
<dd>Thanks.</dd>
</dl>
</dd>
</dl>
<p><a name="Suggest_We_mention_Lack_of_Medication_Approval" id="Suggest_We_mention_Lack_of_Medication_Approval"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Talk%7EAnticonvulsant_3512.html" title="Edit section: Suggest We mention Lack of Medication Approval">edit</a>]</span> <span class="mw-headline">Suggest We mention Lack of Medication Approval</span></h2>
<p>I think its worth mentioning that MANY anti-seizure DRUGS have never been APPROVED FOR CHILD USE by the (FDA) Food and Drug Administration in the United States.muncher 15:51, 23 October 2006 (UTC)</p>
<p><br />
The licensing situation for children is complex and not unique to anticonvulsants. <i>"One recent estimate was that 75 of the 80 medicines most commonly prescribed for newborns and infants were being prescribed off-label."</i>.<a href="http://www.epilepsy.com/epilepsy/medicine_kids.html" class="external autonumber" title="http://www.epilepsy.com/epilepsy/medicine_kids.html" rel="nofollow">[1]</a> Licencing for children often specify several components:</p>
<ol>
<li>The age, for example: 2, 6, 10 years.</li>
<li>The seizure type, for example: generalised seizures.</li>
<li>The syndrome, for example: Lennox-gastaut syndrome.</li>
<li>Combination, for example: either as monotherapy or in-addition to an established drug (adjunctive usage).</li>
</ol>
<p>The older drugs such as phenobarbital, ethosuximide and phenytoin are approved for children effectively by default (they were in use well before modern regulations). Here is the FDA approval status of some of the common modern drugs.</p>
<ul>
<li>Topamax (topiramate) Adjundictve treatment of partial seizures (also seizures in Lennox-Gastaut syndrome) in children 2 years and over.<a href="http://www.centerwatch.com/patient/drugs/dru570.html" class="external autonumber" title="http://www.centerwatch.com/patient/drugs/dru570.html" rel="nofollow">[2]</a><a href="http://www.epilepsyfoundation.org/aboutus/pressroom/n090401.cfm" class="external autonumber" title="http://www.epilepsyfoundation.org/aboutus/pressroom/n090401.cfm" rel="nofollow">[3]</a>. Also monotherapy of partial onset or primary generalized tonic-clonic seizures in children 10 years and over. <a href="http://www.epilepsyfoundation.org/aboutus/pressroom/pr20050630.cfm" class="external autonumber" title="http://www.epilepsyfoundation.org/aboutus/pressroom/pr20050630.cfm" rel="nofollow">[4]</a></li>
<li>Tegretol (carbamazepine) First-line monotherapy for the treatment of partial, secondarily generalized, and generalized tonic-clonic seizures in children. <a href="http://www.centerwatch.com/patient/drugs/dru77.html" class="external autonumber" title="http://www.centerwatch.com/patient/drugs/dru77.html" rel="nofollow">[5]</a></li>
<li>Trileptal (oxcarbazepine). Adjunctive and monotherapy for the treatment of partial seizures in children 4 years and over. <a href="http://www.centerwatch.com/patient/drugs/dru599.html" class="external autonumber" title="http://www.centerwatch.com/patient/drugs/dru599.html" rel="nofollow">[6]</a><a href="http://www.epilepsy.com/epilepsy/medicine_kids.html" class="external autonumber" title="http://www.epilepsy.com/epilepsy/medicine_kids.html" rel="nofollow">[7]</a></li>
<li>Gabitril (tiagabine). Adjunctive treatment of partial seizures in children 12 years and over.<a href="http://www.epilepsy.com/epilepsy/medicine_kids.html" class="external autonumber" title="http://www.epilepsy.com/epilepsy/medicine_kids.html" rel="nofollow">[8]</a></li>
<li>Lamictal (lamotrigine). Adjunctive treatment of generalized seizures in Lennox-Gastaut syndrome.<a href="http://www.epilepsy.com/epilepsy/medicine_kids.html" class="external autonumber" title="http://www.epilepsy.com/epilepsy/medicine_kids.html" rel="nofollow">[9]</a> Also adjunctive treatment of generalised tonic-clonic seizures in children 2 years and over. <a href="http://www.epilepsyfoundation.org/aboutus/pressroom/pr20060929.cfm" class="external autonumber" title="http://www.epilepsyfoundation.org/aboutus/pressroom/pr20060929.cfm" rel="nofollow">[10]</a></li>
<li>Neurontin (gabapentin). Adjunctive treatment of partial seizures in children 3 years and over.<a href="http://www.epilepsy.com/epilepsy/medicine_kids.html" class="external autonumber" title="http://www.epilepsy.com/epilepsy/medicine_kids.html" rel="nofollow">[11]</a></li>
<li>Keppra (levetiracetam). Adjuntive treatment of partial seizures in children 4 years and over.<a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=26559" class="external autonumber" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=26559" rel="nofollow">[12]</a></li>
<li>Depakote ER (divalproex sodium extended-release). Adjunctive and monotherapy for the treatment of partial seizures in children 10 years and above.<a href="http://www.epilepsyfoundation.org/epilepsyusa/depakotefda.cfm" class="external autonumber" title="http://www.epilepsyfoundation.org/epilepsyusa/depakotefda.cfm" rel="nofollow">[13]</a></li>
</ul>
<p>There is a wider choice of licensed drugs for children in the UK.<a href="http://www.epilepsynse.org.uk/pages/info/leaflets/child_AED.cfm" class="external autonumber" title="http://www.epilepsynse.org.uk/pages/info/leaflets/child_AED.cfm" rel="nofollow">[14]</a> <a href="http://www.nice.org.uk/page.aspx?o=ta079guidance" class="external autonumber" title="http://www.nice.org.uk/page.aspx?o=ta079guidance" rel="nofollow">[15]</a>.</p>
<p>There remains a shortage of approved medicines for infants (under 2 years). Getting approval for monotherapy is hard, hence adjunctive therapy is established first. If enough off-licence usage is occurring, there is little incentive on the manufacturer to fund trials to widen the licence. What is interesting is that no epilepsy drugs have ever been compared against placebo (largely for ethical reasons) and that, within its indications, no epilepsy drug has ever been shown to be significantly better than any other (older) drug. Some may, however, be better tolerated.<a href="http://professionals.epilepsy.com/page/ar_1098458683.html" class="external autonumber" title="http://professionals.epilepsy.com/page/ar_1098458683.html" rel="nofollow">[16]</a></p>
<p>Perhaps some of this information could be added to the article. <a href="../../../c/o/l/User%7EColin_66ca.html" title="User:Colin">Colin</a>°<a href="../../../c/o/l/User_talk%7EColin_65e3.html" title="User talk:Colin"><sup>Talk</sup></a> 18:40, 23 October 2006 (UTC)</p>
<p><a name="Adding_for_finding_of_fact" id="Adding_for_finding_of_fact"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Talk%7EAnticonvulsant_3512.html" title="Edit section: Adding for finding of fact">edit</a>]</span> <span class="mw-headline">Adding for finding of fact</span></h2>
<p>Jean P. Davis M.D., and H.H. Ramsey, M.D.</p>
<p>The demonstration of anticonvulsant activity of the tetrahydrocannabinol (THC) cogeners by laboratory tests (Loewe and Goodman, Federation Proc. 6:352, 1947) prompted clinical trial in five institutionalized epileptic children. All of them had symptomatic grand mal epilepsy with retardation; three has cerebral palsy in addition. EEG tracings were grossly abnormal in the entire group; three has focal seizure activity. Their attacks had been inadequately controlled on 0.13 gm. of Phenobarbital daily, combined with 0.3 gm. of Dilantin per day in two of the patients, and in a third, with 0.2 gm. of Mesantoin daily.</p>
<p>Two isomeric 3(1,2-dimethyl heptyl) homologs of THC were tested, numbers 122 and 125A, with ataxia potencies 50 and 8 times, respectively, that of natural Marijuana principles. Number 122 was given to 2 patients for 3 weeks and to 3 patients for 7 weeks. 3 responded at least as well to previous therapy; the 4th became almost completely and the 5th entirely seizure free. One patient transferred to 125A after 3 weeks, had prompt exacerbation of seizures during the ensuing 4 weeks, despite dosages up to 4 mg. daily. The 2nd patient transferred to 125A was adequately controlled on this dosage, except for a brief period of paranoid behavior three and a half weeks later; similar episodes had occurred prior to cannabinol therapy. Other psychic disturbances or toxic reactions were not manifested during the periods of treatment. Blood counts were normal. The cannabinoids herein reported deserve further trial in non-institutionalized epileptics. Reprinted from Federation Proceedings, Federation of American Society for Experimental Biology, vol 8, 1949, p.284.</p>
<p>These proceedings demonstrate unequivocally the Anticonvulsant properties of cannabinods. This is not opinion but fact and is therefore "absolute and non-negotiable" in accordance with <a href="../../../n/p/o/WP%7ENPOV_1d4d.html" title="WP:NPOV">WP:NPOV</a>. Adding cannabinoids. <a href="../../../a/l/p/User%7EAlphaquad_7c93.html" title="User:Alphaquad">Alphaquad</a> 22:05, 19 March 2007 (UTC)</p>
<dl>
<dd>
<dl>
<dd>Tetrahydrocannabinol is not professionally <b>used</b> as an anticonvulsant. It (or related compounds) are being researched as such, along with thousands of other chemicals. This article should not mention all drugs that have some anticonvulsant effect - it would be uselessly long. <a href="../../../c/o/l/User%7EColin_66ca.html" title="User:Colin">Colin</a>°<a href="../../../c/o/l/User_talk%7EColin_65e3.html" title="User talk:Colin"><sup>Talk</sup></a> 22:08, 19 March 2007 (UTC)</dd>
</dl>
</dd>
</dl>
<dl>
<dd>
<dl>
<dd>
<dl>
<dd>Length is not an issue for a single entry. Your persistence shows a biased opinion against this one item and is contrary wiki standards <small>—The preceding <a href="../../../s/i/g/Wikipedia%7ESign_your_posts_on_talk_pages_ee53.html" title="Wikipedia:Sign your posts on talk pages">unsigned</a> comment was added by <a href="../../../a/l/p/User%7EAlphaquad_7c93.html" title="User:Alphaquad">Alphaquad</a> (<a href="../../../a/l/p/User_talk%7EAlphaquad_e8d2.html" title="User talk:Alphaquad">talk</a> • <a href="../../../c/o/n/Special%7EContributions_Alphaquad_16ce.html" title="Special:Contributions/Alphaquad">contribs</a>) 22:17, 19 March 2007 (UTC).</small></dd>
</dl>
</dd>
</dl>
</dd>
</dl>

<!-- 
Pre-expand include size: 3559 bytes
Post-expand include size: 1246 bytes
Template argument size: 136 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/t/Talk%7EAnticonvulsant_3512.html">http://en.wikipedia.org../../../a/n/t/Talk%7EAnticonvulsant_3512.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../u/n/a/Category%7EUnassessed_pharmacology_articles_fbac.html" title="Category:Unassessed pharmacology articles">Unassessed pharmacology articles</a></span> | <span dir='ltr'><a href="../../../u/n/k/Category%7EUnknown-importance_pharmacology_articles_9651.html" title="Category:Unknown-importance pharmacology articles">Unknown-importance pharmacology articles</a></span> | <span dir='ltr'><a href="../../../w/i/k/Category%7EWikiProject_Pharmacology_articles_34b4.html" title="Category:WikiProject Pharmacology articles">WikiProject Pharmacology articles</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       	       ><a href="../../../a/n/t/Anticonvulsant.html">Article</a></li><li id="ca-talk"
	       class="selected"	       ><a href="../../../a/n/t/Talk%7EAnticonvulsant_3512.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Talk:Anticonvulsant">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 17:11, 22 March 2007 by Wikipedia user <a href="../../../c/o/l/User%7EColin_66ca.html" title="User:Colin">Colin</a>. Based on work by Wikipedia user(s) <a href="../../../h/a/g/User%7EHagermanBot_d869.html" title="User:HagermanBot">HagermanBot</a>, <a href="../../../a/l/p/User%7EAlphaquad_7c93.html" title="User:Alphaquad">Alphaquad</a>, <a href="../../../c/h/a/User%7EChaos_b7c8.html" title="User:Chaos">Chaos</a>, <a href="../../../s/p/i/User%7ESpiperon_5ebb.html" title="User:Spiperon">Spiperon</a> and Jollygood and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
